Etanercept in Wegener's granulomatosis: A six-month open-label trial to evaluate safety.

被引：0
|
作者：
Stone, J
Uhlfelder, M
Hellmann, D
Crook, S
Bedoes, N
Hoffmann, G
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2000年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2024
引用
收藏
页码：S404 / S404
页数：1
相关论文
共 50 条
  • [21] Damage from Wegener's granulomatosis and its treatment: Prospective data from the Wegener's granulomatosis Etanercept Trial (WGET).
    Seo, P
    Min, N
    Holbrook, JT
    Hoffman, GS
    Specks, U
    Merkel, PA
    Spiera, R
    Davis, JC
    St Clair, EW
    McCune, J
    Tibbs, A
    Luqmani, R
    Stone, JH
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S231 - S231
  • [22] Impact of Donepezil and Memantine on Behavioral and Psychological Symptoms of Alzheimer Disease: Six-month Open-label Study
    Rozankovic, Petra Bago
    Rozankovic, Marjan
    Badzak, Jasna
    Stojic, Maristela
    Sporis, Ivana Susak
    COGNITIVE AND BEHAVIORAL NEUROLOGY, 2021, 34 (04) : 288 - 294
  • [23] Long-term lumateperone treatment in bipolar disorder: Six-month open-label extension study
    Tohen, Mauricio
    D'Souza, Ian
    Kozauer, Susan G.
    Chen, Changzheng
    Durgam, Suresh
    BIPOLAR DISORDERS, 2023, 25 : 96 - 96
  • [24] An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's)
    Langford, Carol A.
    Monach, Paul A.
    Specks, Ulrich
    Seo, Philip
    Cuthbertson, David
    McAlear, Carol A.
    Ytterberg, Steven R.
    Hoffman, Gary S.
    Krischer, Jeffrey P.
    Merkel, Peter A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (07) : 1376 - 1379
  • [25] Vitamin E treatment in patients with nonalcoholic steatohepatitis: A six-month, open-label study of sixteen patients
    Yakaryilmaz, F
    Guliter, S
    Ozenirler, S
    Erdem, O
    Akyol, G
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2004, 65 (03): : 266 - 277
  • [26] Long-Term Lumateperone Treatment in Bipolar Disorder: Six-Month Open-Label Extension Study
    Tohen, Mauricio
    Durgam, Suresh
    Kozauer, Susan
    D'Souza, Ian
    Chen, Richard
    Mates, Sharon
    CNS SPECTRUMS, 2023, 28 (02) : 233 - 233
  • [27] Damage caused by Wegener's granulomatosis and its treatment - Prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)
    Seo, P
    Min, YI
    Holbrook, JT
    Hoffman, GS
    Merkel, PA
    Spiera, R
    Davis, JC
    Ytterberg, SR
    St Clair, EW
    McCune, WJ
    Specks, U
    Allen, NB
    Luqmani, RA
    Stone, JH
    ARTHRITIS AND RHEUMATISM, 2005, 52 (07): : 2168 - 2178
  • [28] A SIX-MONTH OPEN-LABEL MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF PRC-063 IN ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
    Kollins, Scott H.
    Cutler, Andrew J.
    Khattak, Sohail
    Weiss, Margaret D.
    Donnelly, Graeme
    Reiz, Joseph L.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10) : S217 - S217
  • [29] Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer's Disease: A Six-Month, Open-Label, Observational Study
    Padovani, Alessandro
    Caratozzolo, S.
    Benussi, A.
    Galli, A.
    Rozzini, L.
    Cosseddu, M.
    Turrone, R.
    Pilotto, A.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2024, 11 (02): : 329 - 338
  • [30] Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer’s Disease: A Six-Month, Open-Label, Observational Study
    Alessandro Padovani
    S. Caratozzolo
    A. Benussi
    A. Galli
    L. Rozzini
    M. Cosseddu
    R. Turrone
    A. Pilotto
    The Journal of Prevention of Alzheimer's Disease, 2024, 11 : 375 - 381
12345